Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Biotech
Pfizer signs $1.9B pact for Fosun unit's GLP-1 drug
Pfizer’s bidding war for Metsera hasn’t satiated the pharma’s appetite for GLP-1 therapies—at least going by this morning’s $1.9 billion biobucks deal.
James Waldron
Dec 9, 2025 8:00am
Lilly looks to become innovation ‘backbone,’ exec says
Dec 8, 2025 12:05pm
Wave, Structure stocks double on obesity data readouts
Dec 8, 2025 10:50am
Ascletis reports 7.7% weight loss for oral GLP-1 contender
Dec 8, 2025 8:35am
Novo expands pivotal program after amycretin shines in diabetes
Nov 25, 2025 7:44am
Vanda tackles Wegovy-driven vomiting, sparking race to ph. 3
Nov 18, 2025 10:44am
